video
GDHIPEC: Internationally Recognized and Utilized

Applicable to Multiple Body Cavities・Minimally Invasive Performance・Superior Control of Metastatic Progression・Advanced Management of Malignant Effusion

MORE +
Scroll Down

GOOD DOCTOR ·

2007

Company was founded

2200

Manufacturing facilities

30000 +

Times of successful performance

20 +

Independent Intellectual Property Rights

Xi’an Good Doctor Medical Science Technology Co., Ltd.

Manufacturer of the GDHIPEC System

Innovation in HIPEC & HITHOC Technology

Your Reliable Partner in Hyperthermic Perfusion

GDPR-2100S

Innovation in HIPEC Technology The Most Advanced Hyperthermic Perfusion System in China

The Most Advanced Hyperthermic Perfusion System in China


GDPR-2100S from the GDHIPEC, the most reliable and dedicated system (equipment and consumable accessories) for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Hyperthermic Intrathoracic Chemotherapy (HITHOC) in China.

Learn more

Minimally Invasive Treatment

Precise Temperature Control

Outstanding Clinical Performance

Innovative “One-way” Lavage Technology

Applicable for Both Surgical and Medical Oncology

GDPR-2100T

Innovation in HIPEC Technology The Most Advanced Hyperthermic Perfusion System in China

The Most Advanced Hyperthermic Perfusion System in China


GDPR-2100T from the GDHIPEC, the most reliable and dedicated system (equipment and consumable accessories) for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Hyperthermic Intrathoracic Chemotherapy (HITHOC) in China.

Learn more

GDHIPEC ·

 Good Doctor

GDHIPEC

Broadly Applicable to Both Surgical and Medical Oncology Treatment Strategies

Multiple cavities・Minimal damage・Control metastasis・Treat effusion

 

Learn more
视频标题
Good Doctor
Good Doctor
more

Academic publications & professional resources

Members login to learn more>>

Holds more than 20 independent intellectual property rights

Internet Drug Information Service Qualification Certificate

Internet Drug Information Service Qualification Certificate

High-tech Enterprise Certificate

High-tech Enterprise Certificate

Medical Device Business License

Medical Device Business License

Business License

Business License

European Community CE (COMMUNATE EUROPEIA) certification

European Community CE (COMMUNATE EUROPEIA) certification

Newest ISO 13485 Certificate

Newest ISO 13485 Certificate

Keep abreast of market dynamics, focus on Good Doctor information

BLOG

The National Cancer Center has just released: 2024 National Cancer Report

Recently, with the approval of the National Health Commission, the National Cancer Center released the 2022 burden of malignant tumors in China based on the latest data from tumor registration and follow-up monitoring on JNCC. The results released this time are jointly calculated by the National Cancer Center and the International Agency for Research on Cancer (IARC), consistent with the Chinese data published by IARC in GLOBOCAN 2022 and released simultaneously.


2024-09-26